Ignite Creation Date:
2024-05-05 @ 4:45 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00307567
Status:
COMPLETED
Last Update Posted:
2016-09-23
First Post:
2006-03-07
Brief Title:
Multicentre Booster Immune Memory Study of a Booster Dose of GSK Biologicals 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths Previously Vaccinated in Study 103488
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
A Phase II Multicentre Booster Study to Evaluate Booster Vaccination With GSK Biologicals 10-valent Pneumococcal Conjugate Vaccine or to Evaluate the Immune Memory Following the Administration of a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Previously Vaccinated in Infancy in the Primary Study 11PN-PD-DIT-002 103488
Status:
COMPLETED
Status Verified Date:
2016-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Booster and immune memory study
Detailed Description:
Total All 689 subjects enrolled in study 103488 23PS group Aventis Pasteurs 23-valent polysaccharide pneumococcal vaccine Pneumovax 23 DTPa-HBV-IPVHib 10V group GSK Biologicals 10-valent pneumococcal conjugate vaccine DTPa-HBV-IPVHib
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None